Diflucortolone valerate (BAY866146)
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
20
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development
Conditions
Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development
Trial Timeline
Nov 16, 2018 → Nov 29, 2018
NCT ID
NCT03788863About Diflucortolone valerate (BAY866146)
Diflucortolone valerate (BAY866146) is a pre-clinical stage product being developed by Bayer for Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development. The current trial status is completed. This product is registered under clinical trial identifier NCT03788863. Target conditions include Relationship Between the Exposure of Glucocorticoids During Pregnancy and Orofacial Cleft Development.
Hype Score Breakdown
Clinical
5
Activity
2
Company
7
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03788863 | Pre-clinical | Completed |